Brain pacemaker trial targets Tough-to-Treat OCD

NCT ID NCT06347978

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests a personalized deep brain stimulation (DBS) approach for people with severe obsessive-compulsive disorder (OCD) that hasn't improved with standard treatments. Ten adults will first undergo brain mapping to find the best stimulation targets, then receive a DBS device. Half will have the device turned on first, then off, and the other half the reverse, to compare effects. The goal is to see if this method is safe and can reduce OCD symptoms.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
deep brain stimulation (DBS) device
What this could lead to
If successful, this could point toward a new treatment option for people with severe OCD that hasn't responded to standard therapies.
What could go wrong
This is a very small, early feasibility trial with only 10 participants. It is designed mainly to test safety and whether the approach works, not to prove effectiveness. Brain surgery carries risks like infection or bleeding.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBSESSIVE-COMPULSIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of California, San Francisco

    San Francisco, California, 94143, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.